Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harnessing Knowledge on Very Important Pharmacogenes CYP2C9 and CYP2C19 Variation for Precision Medicine in Resource-Limited Global Conflict Zones.

Omics : a journal of integrative biology - 1 Oct 2016

Barlas İbrahim Ömer, Sezgin Orhan, Dandara Collet, Türköz Gözde, Yengel Emre, Cindi Zinhle, Ankaralı Handan, Şardaş Semra

Abstract excerpt

Pharmacogenomics harnesses the utility of a patient's genome (n = 1) in decisions on which therapeutic drugs and in what amounts should be administered. Often, patients with shared ancestry present with comparable genetic profiles that predict drug response. However, populations are not static, thus, often, population mobility through migration, especially enmasse as is seen for refugees, changes the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2C19
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug-Related Side Effects and Adverse Reactions

Share to Mediterranean Region

Share to Pharmacogenomic Testing

Share to Pharmacogenomic Variants

Share to Transients and Migrants

Source

Identifiers

PMID: 27726640
DOI: 10.1089/omi.2016.0133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harnessing Knowledge on Very Important Pharmacogenes CYP2C9 and CYP2C19 Variation for Precision Medicine in Resource-Limited Global Conflict Zones.PMID 27726640Read ↗

Major Allele Frequencies in CYP2C9 and CYP2C19 in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial CategoriesSemantic proximity Read ↗

Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across EuropeSemantic proximity Read ↗

Major Allele Frequencies in <em>CYP2C9</em> and <em>CYP2C19</em> in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial CategoriesSemantic proximity Read ↗

Pharmacokinetic recall study of Estonian Biobank participants carrying novel genetic variants in CYP2C19 and CYP2D6Semantic proximity Read ↗

Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.Semantic proximity Read ↗

Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Semantic proximity Read ↗

From genes to drugs: CYP2C19 and pharmacogenetics in clinical practiceSemantic proximity Read ↗

Global distribution of functionally important CYP2C9 alleles and their inferred metabolic consequences.Semantic proximity Read ↗

PharmFreq: a comprehensive atlas of ethnogeographic allelic variation in clinically important pharmacogenes.Semantic proximity Read ↗

Allelic frequencies of 60 pharmacogene variants assessed within a Burmese population residing in northeast Indiana, USA.Semantic proximity Read ↗

Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences.Semantic proximity Read ↗

Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.